- Home
- YMAB vs NYMT Comparison
YMAB vs NYMT Comparison
Compare YMAB & NYMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- NYMT
- Stock Information
- Founded
- YMAB 2015
- NYMT 2003
- Country
- YMAB United States
- NYMT United States
- Employees
- YMAB N/A
- NYMT N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- NYMT Real Estate Investment Trusts
- Sector
- YMAB Health Care
- NYMT Real Estate
- Exchange
- YMAB Nasdaq
- NYMT Nasdaq
- Market Cap
- YMAB 482.4M
- NYMT 516.8M
- IPO Year
- YMAB 2018
- NYMT 2004
- Fundamental
- Price
- YMAB $6.19
- NYMT $6.00
- Analyst Decision
- YMAB Strong Buy
- NYMT Buy
- Analyst Count
- YMAB 10
- NYMT 5
- Target Price
- YMAB $21.10
- NYMT $7.13
- AVG Volume (30 Days)
- YMAB 417.3K
- NYMT 831.9K
- Earning Date
- YMAB 02-27-2025
- NYMT 02-19-2025
- Dividend Yield
- YMAB N/A
- NYMT 13.39%
- EPS Growth
- YMAB N/A
- NYMT N/A
- EPS
- YMAB N/A
- NYMT N/A
- Revenue
- YMAB $84,553,000.00
- NYMT $252,541,000.00
- Revenue This Year
- YMAB $6.09
- NYMT N/A
- Revenue Next Year
- YMAB $19.62
- NYMT $45.89
- P/E Ratio
- YMAB N/A
- NYMT N/A
- Revenue Growth
- YMAB N/A
- NYMT 139.48
- 52 Week Low
- YMAB $6.01
- NYMT $5.14
- 52 Week High
- YMAB $20.90
- NYMT $8.51
- Technical
- Relative Strength Index (RSI)
- YMAB 19.68
- NYMT 50.15
- Support Level
- YMAB $6.05
- NYMT $5.53
- Resistance Level
- YMAB $6.81
- NYMT $6.07
- Average True Range (ATR)
- YMAB 0.49
- NYMT 0.17
- MACD
- YMAB -0.02
- NYMT -0.00
- Stochastic Oscillator
- YMAB 6.90
- NYMT 54.65
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.